Notice of interruption or termination of supply of a human drug
 Date ▼HolderCodeDrugDate fromSubject
 17.4.2019ratiopharm GmbH (RAT)21205Telmisartan ratiopharm 80 mg (tbl 28x80 mg (blis.Al/Al))1.8.2019Z
 17.4.2019TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)93260HERPESIN 250 (plv inf 10x250 mg (liek.skl.))1.8.2019Z
 17.4.2019LEO Pharma A/S (LEO-2)97639Skinoren krém (crm 1x30 g (tuba Al))18.4.2019R
 17.4.2019Aspen Pharma Trading Limited (ASE-1)90021Marcaine spinal 0,5 % heavy (sol inj 5x4 ml/20 mg (amp.skl.))17.4.2019R
 18.4.2019Teva Czech Industries s.r.o. (TEV-CZ-2)58780Ecobec 100 µg Easi-Breathe (aer ora 200x100 µg/1 dávka (obal Al tlak.+aplik.))26.4.2019O
 18.4.2019Teva Czech Industries s.r.o. (TEV-CZ-2)58782Ecobec 250 µg Easi-Breathe (aer ora 200x250 µg/1 dávka (obal Al tlak.+aplik.))26.4.2019O
 18.4.2019Actavis Group PTC ehf. (ACT-5)80016Irbesartan Actavis 300 mg (tbl flm 84x300 mg (blis.PVC/PVDC/Al))1.10.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80020Irbesartan Actavis 300 mg (tbl flm 60x300 mg (fľ.HDPE))15.12.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80019Irbesartan Actavis 300 mg (tbl flm 30x300 mg (fľ.HDPE))25.4.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80003Irbesartan Actavis 150 mg (tbl flm 84x150 mg (blis.PVC/PVDC/Al))24.1.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)79737Irbesartan Actavis 150 mg (tbl flm 28x150 mg (blis.PVC/PVDC/Al))25.4.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80013Irbesartan Actavis 300 mg (tbl flm 28x300 mg (blis.PVC/PVDC/Al))25.4.2019Z
 23.4.2019Zentiva, k.s. (ZNT-1)01066FRAMYKOIN (ung der 1x10 g (tuba Al))24.4.2019O
 23.4.2019Octapharma (IP) SPRL (OCP-BE-1)45372Octagam (sol inf 1x20 ml (liek.skl.))1.6.2019R
 23.4.2019Octapharma (IP) SPRL (OCP-BE-1)12691Octagam (sol inf 1x50 ml (fľ.skl.))1.6.2019R

Subject means: R-Break, O-Renew or Z-Cancellation of human drug delivery


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)